Andrea Beth Troxel ScD

faculty photo
Professor of Biostatistics in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
Department: Biostatistics and Epidemiology
Graduate Group Affiliations

Contact information
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania, School of Medicine
423 Guardian Drive - 632 Blockley Hall
Philadelphia, PA 19104-6021
Office: 215-573-0659
Fax: 215-573-4865
B.S. (Applied Mathematics)
Yale University, 1991.
Sc.D. (Biostatistics)
Harvard University, 1995.
Permanent link

Description of Research Expertise

longitudinal studies, missing data, quality of life, oncology

Selected Publications

Gopalan A., Tahirovic E., Moss H., Troxel A.B., Zhu J., Loewenstein G., Volpp K.G.: Translating the Hemoglobin A1C with More Easily Understood Feedback: A Randomized Controlled Trial. Journal of General Internal Medicine 2014, In press.

Callis Duffin K., Yeung H., Takeshita J., Krueger G.G., Robertson A.D., Troxel A.B., Shin D.B., Van Voorhees A.S., Gelfand JM.: Patient Satisfaction with Treatments for Moderate-to-Severe Plaque Psoriasis in Clinical Practice. The British Journal of Dermatology 170(3): 672-80, March 2014.

Dommasch E.D., Troxel A.B., Gelfand J.M.: Counterpoint: A tale of two meta-analyses revisited. Journal of the American Academy of Dermatology 70(2): 381-3, February 2014.

Ogdie A., Haynes K., Troxel A., Love T., Choi H.K.and Gelfand J.: Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Annals of Rheumatic Disease 73(1): 149-53, January 2014.

Ciunci C.A., Perini R.F., Avadhani A.N., Kang H.C., Sun W., Redlinger M., Harlacker K., Flaherty K.T., Giantonio B.J., Rosen M.A., Divgi C.R., Song H.K., Englander S., Troxel A., Schnall M., O'Dwyer P.J.: Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer. Cancer 120(1): 77-85, January 2014.

Wysocka M., Kossenkov A.V., Benoit B.M., Troxel A.B., Singer E., Schaffer A., Kim B., Dentchev T., Nagata S., Ise T., Showe L.C., Rook A.H.: CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in S├ęzary Syndrome patients. Journal of Investigative Dermatology 134(1): 229-36, January 2014.

Harhay M., Lin E., Pai A., Harhay M.O., Huverserian A., Mussell A., Abt P., Levine M., Bloom R., Shea J.A., Troxel A.B., Reese PP: Early rehospitalization after kidney transplantation: assessing preventability and prognosis. American Journal of Transplantation 13(12): 3164-72, December 2013.

Beatty G.L., Torigian D.A., Chiorean E.G., Saboury B., Brothers A., Alavi A., Troxel A.B., Sun W., Teitelbaum U.R., Vonderheide R.H. and O'Dwyer P.: A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma. Clinical Cancer Research 19(22): 6286-95, November 2013.

Yeung H., Takeshita J., Mehta N.N., Kimmel S.E., Ogdie A., Margolis D.J., Shin D.B., Attor R., Troxel A.B., Gelfand J.M.: Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatology 149(10): 1173-79, October 2013.

de Blank P., Zaoutis T., Fisher B., Troxel A., Kim J., Aplenc R.: Trends in Clostridium Difficile Infection and risk factors for hospital acquisition of Clostridium Difficile among children with cancer. Journal of Pediatrics 163(3): 699-705, September 2013.

back to top
Last updated: 07/29/2014
The Trustees of the University of Pennsylvania